Ablynx NV
Sanofi is a global healthcare leader dedicated to transforming the practice of medicine through science and innovation. With a rich history spanning over a century, Sanofi focuses on developing medicines and vaccines that improve lives and protect public health. The company is committed to scientific excellence, social impact, sustainability, diversity, and inclusion, aiming to make a positive difference worldwide.
Industries
Nr. of Employees
large (251-1000)
Products
Vaccine portfolio
Multiple vaccines covering infectious disease targets and national immunization priorities, developed using multiple platform technologies.
Specialty and general medicines
Portfolio of prescription medicines across immunology, oncology, neurology, rare diseases, diabetes and cardiovascular disease.
Consumer healthcare products (OTC)
Over-the-counter healthcare products for self-care and common conditions, supported by consumer education initiatives.
Vaccine portfolio
Multiple vaccines covering infectious disease targets and national immunization priorities, developed using multiple platform technologies.
Specialty and general medicines
Portfolio of prescription medicines across immunology, oncology, neurology, rare diseases, diabetes and cardiovascular disease.
Consumer healthcare products (OTC)
Over-the-counter healthcare products for self-care and common conditions, supported by consumer education initiatives.
Services
Clinical trial operations and investigator partnerships
Management and sponsorship of Phase I–IV clinical studies including site selection, investigator engagement, ethics and regulatory submissions, and patient recruitment strategies with remote participation options.
Pharmacovigilance and safety reporting
Centralized systems for adverse event intake, assessment and reporting to health authorities and healthcare professionals, with public information resources.
Patient support programmes
Programs offering education, disease management support and tailored assistance for patients and caregivers living with chronic or complex conditions.
Manufacturing and distribution operations
GMP production and regional distribution capabilities for vaccines and pharmaceuticals, supported by inventory management and logistics communications.
Product information and market notifications
Publication of public notices related to product discontinuations, temporary shortages, supply regularization and voluntary recalls to inform regulators, healthcare professionals and the public.
Partnerships, scholarships and community programmes
Collaborations with universities, NGOs and community organisations to support education, workforce development and social impact initiatives.
Clinical trial operations and investigator partnerships
Management and sponsorship of Phase I–IV clinical studies including site selection, investigator engagement, ethics and regulatory submissions, and patient recruitment strategies with remote participation options.
Pharmacovigilance and safety reporting
Centralized systems for adverse event intake, assessment and reporting to health authorities and healthcare professionals, with public information resources.
Patient support programmes
Programs offering education, disease management support and tailored assistance for patients and caregivers living with chronic or complex conditions.
Manufacturing and distribution operations
GMP production and regional distribution capabilities for vaccines and pharmaceuticals, supported by inventory management and logistics communications.
Product information and market notifications
Publication of public notices related to product discontinuations, temporary shortages, supply regularization and voluntary recalls to inform regulators, healthcare professionals and the public.
Partnerships, scholarships and community programmes
Collaborations with universities, NGOs and community organisations to support education, workforce development and social impact initiatives.
Expertise Areas
- Clinical trial management
- Decentralized and patient‑centric clinical operations
- Vaccine research and manufacturing
- Immunology and inflammation drug development
Key Technologies
- mRNA vaccine platforms
- Biologics manufacturing platforms
- Antibody‑drug conjugates (ADCs)
- Artificial intelligence for drug discovery